Key result
Abdominal obesity with diabetes linked to ~69% higher all-cause mortality vs. no abdominal obesity.
Why the study?
Does abdominal obesity combined with dysglycemia increase the risk of metabolic abnormalities and mortality in adults?
Cohort (n=11,580)
Yes
Does abdominal obesity combined with dysglycemia increase the risk of metabolic abnormalities and mortality in adults?
Answers are grounded in this paper and cite their sources.
Abdominal obesity combined with prediabetes or diabetes is associated with a significantly increased burden of metabolic abnormalities and higher risks of all-cause and cardiovascular mortality.
Background Abdominal obesity (AO) has been considered a prevalent risk factor for metabolic complications and cardiovascular disease (CVD). The disproportionate burden of metabolic abnormalities and diabetes status may be a key driver of mortality disparities in individuals with AO. However, the prevalence of coexisting metabolic abnormalities and mortality among individuals with AO based on diabetes status is largely unknown. Purpose To examine the associations of AO with metabolic abnormalities, as well as all-cause death and cardiovascular death in individuals with different diabetes status. Methods Cohort analyses were conducted among 20-to-74-year-old participants in the National Health and Nutrition Examination Survey (NHANES) from 1988 to 1994 with complete examination, metabolic indicators, and mortality data. We examine the AO and diabetes status in relation to metabolic abnormalities, all-cause death, and CV death. Results Among 11,580 participants, the prevalence of non-diabetic AO, AO with prediabetes, AO with diabetes was 19.7%, 12.6%, and 4.9%, respectively. Compared with no AO, AO with diabetes was associated with higher number of metabolic abnormality (OR: 30.36, 95% CI: 24.30, 37.93, P<0.001). NFALD, dyslipidemia, hypertension and insulin resistance are mostly clustered in AO with prediabetes or diabetes. Additionally, AO with dysglycemia had increased risks of all-cause death (prediabetes: HR: 1.22, 95% CI: 1.06, 1.41, P=0.008; diabetes: HR: 1.69, 95% CI: 1.46, 1.96, P<0.001) and CV death (prediabetes: HR: 1.51, 95% CI: 1.25, 1.82, P<0.001; diabetes: HR: 1.99, 95% CI: 1.56, 2.53, P<0.001). Conclusions Individuals with AO and dysglycemia was associated with increased number of metabolic abnormalities, and higher risk of all-cause death and CV death.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) conducted a cohort in Abdominal obesity and dysglycemia (n=11,580). Abdominal obesity with diabetes vs. No abdominal obesity was evaluated on All-cause death (HR 1.69, 95% CI 1.46-1.96, p=<0.001). Abdominal obesity with diabetes was associated with a increased risk of all-cause death compared to individuals without abdominal obesity.
Synapse has enriched 10 related papers. Consider them for comparative context: